- Benchmark ASINB0GVST1FR1
- MarketplaceUS
- Category ID13053141
- Analyzed Products
- Keywordhome health
- Price Range-
- Minimum Net Profit Margin10.00%
- MOQ100
- Est. Purchasing CostNo price data
- Data Date2026-07-28
- Your Budget (for new listing) (CNY)¥500,000.00
Report summary from Keble AI Agent: Listing
这个市场不适合进入：目前只看到 1 个新品牌 feangli，2 个新上架里只有 1 个赚钱、1 个失败，表面成功率 50%，但样本太小，不能当成可复制机会；更关键的是，赚钱的那条路不是低成本模式，而是靠 53.13 美元定价、38.22% 毛利、每月 200 件销量和明显的功能差异化撑起来的。对小商家和跨类目大品牌来说，这都不是“轻松切入”的市场，而是一个要靠较高研发和投放才能搏结果的品类。
Recommended Products Features Direction
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
New Brands
VS
Old Brands
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
New Brands
#Budget Requirement
Listing这不是适合进入的市场。预算上你“能买得起”单个ASIN的入场门槛，但市场本身已经明显走向高风险：新品牌里只有1个成功、1个失败，成功率50%，样本太小；更关键的是当前只有一个可验证盈利产品，且另一款新品直接失败，说明不是稳定可复制的机会。
你的预算是500000 CNY，按样本里唯一可验证的成功款 B0GVST1FR1 来看，售价约53.13美元，月销约200件，月收入约10626美元，毛利率38.22%，这类单品的前期供应链+头程+广告显然在你的预算可覆盖范围内；但工具也明确提示，这类预算只覆盖前几个月，不含研发、品牌和认证，而这个类目又是高研发压力市场，意味着你能启动，不代表你能长期打赢。更要命的是，B0GHRFLDTQ 这条新品直接失败，说明同一品牌下新品并不是“上新就能跑出来”，需要明显差异化；而成功款 B0GVST1FR1 的卖点是“三波长红光+近红外+5档振动+定时自动关机”，本质上是靠功能堆叠和差异化去打，而不是低价硬拼。按你的规则，这种市场绝不是适合多数小商家硬闯的地方。**
对大品牌来说，能参考的只有 feangli 这类新品牌里跑出来的成功款 B0GVST1FR1；对小商家来说，B0GVST1FR1 不是“低成本小卖家模板”，更像是一个带功能创新、需要较强推广预算的样本，B0GHRFLDTQ 则是明确的避坑案例。当前没有老品牌样本可作为“小商家成功范例”，所以小商家不该拿老品牌打法当参照；如果硬要进，至少要准备接近该成功款的功能差异化和营销强度，否则就是在一个高研发、高推广、且已有失败信号的市场里赌命。建议结论很直接：不要进入。
Early sourcing + logistics + marketing budget (USD)N/AExplains the budgetWith all these investments, who has profitable new releases
How many new listings are released by old brands?0.00%New listing success rate (new brands):50.00%Which new brands have these successful new listings?Other major expensesR&DAlternatives- 普通护膝/加压护膝：比红光理疗护膝便宜很多，使用门槛低，适合想先缓解日常活动中的支撑和保暖需求的用户。
- 可重复使用热敷护膝垫：只提供热疗，没有红光和复杂模式，价格通常更低，操作也更简单，适合偏好基础舒缓的人群。
- 一次性膝关节热敷贴/暖贴：单次成本低、购买方便、外出也容易用，适合短期、临时性膝部不适的替代方案。
- 冰敷护膝袋/冷敷凝胶包：对于运动后肿胀或急性不适更直接，成本低、家庭常备即可使用，替代性较强。
- 弹力绷带或自粘运动绷带：几乎是最低成本的膝部支撑替代品，适合轻度压迫和稳定需求，不需要充电或设备维护。
- 手动按摩工具（如滚轮/按摩球/筋膜球）：一次购买后可用于多个部位，价格较低，适合想要简单放松肌肉而不追求仪器理疗的人。
- 物理治疗门诊的单次治疗/评估：如果用户不想自购设备，这种按次付费方式更灵活，能获得更明确的个体化建议，适合风险控制。
Alternative solutions may pose a risk to your investment in certain markets.
#Brands Investment Analysis
Listing结论：这个市场现在不适合进入。 目前只看到1个新品牌 feangli，样本很小，但结果已经足够说明方向：新品牌新品盈利率只有50%，且 2026 年 1 月上新的 B0GHRFLDTQ 直接失败；唯一跑出来的 B0GVST1FR1 虽然能赚钱，但靠的是更强功能组合和可穿戴理疗定位，不是普通护膝改款就能复制。
Least investment in new productsNew products with Highest revenueMost investment in new productsfeangli
Recent Monthly Revenue (USD):$10,626.00(200pcs/month)B0GVST1FR1 (4.4/5 (125 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitable#Differentiations
Unique productsCommon productsDifferentiation:- Product features and designs are too common without differentiation
B0GVST1FR1 (4.4/5 (125 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitableSales & BSR
Differentiation:- Product features and designs are too common without differentiation
B0GHRFLDTQBrand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQSales & BSR
#Net Profit Margins: All vs New
Listing结论很明确：这个市场目前不适合进入，也不该推进。现有数据只覆盖 1 个新品牌 feangli，样本太小，但它已经把门槛说得很清楚：新品牌要拿到盈利，单品通常得先投约 15,865.68 美元起步，靠的是 38.2% 的利润率和 200 单/月的主动销售；这不是低成本、低风险市场，而是需要持续投放和较强运营能力的市场。
证据上看，市场并没有出现“可复制的小商家机会”，而是更像高投入驱动的单点成功。 feangli 目前只有 2 个新产品，1 个赚钱、1 个不赚钱，品牌成功率 50%，但这个成功率没有代表性，因为总样本只有 2 个；赚钱的 B0GVST1FR1 售价 53.13 美元，最近月销 200 件，月利润 4,061.26 美元，利润率 38.2%，早期投入 15,865.68 美元，说明要做出结果必须有足够前置资金和执行力。更关键的是，这里没有任何老品牌案例可供参考，也没有发现 30~100+ 新品牌涌入的 oversaturation 信号；但由于盈利样本极少、非盈利样本同样存在，且没有足够多的“真实小商家成功案例”(<300 reviews/year 之外还要能稳定复制)，所以不能把它当成小商家可安全进入的市场。当前最可执行的结论是：大品牌若要进场，需要准备至少对标 15k+ 美元级别的单品启动资金并接受高波动；小商家则不建议进入，因为还看不到不依赖激进投放或强品牌力的稳定成功路径。
Profitability difficultyUnknown - Insufficient New ReleasesAll products distribution on different profit levels
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%otherNew products distribution on different profit levels
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%other#Top Products by Net Profit Margin
Top 20 Profitable Products
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
B0GVST1FR1feangli2026-05-30Yes$53.13200pcs$10626.038.22%$4061.26Top 20 Profitable New Products
Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.
B0GVST1FR1feangli2026-05-30Yes$53.13200pcs$10626.038.22%$4061.26#New Product Success Rates
Listing这个市场目前不值得进入：样本里只有 1 个新品牌 feangli，且新品牌新上架成功率只有 50%，但这并不代表容易做；真正能赚钱的只有 B0GVST1FR1，另一个新上架 B0GHRFLDTQ 直接失败。 更关键的是，盈利 ASIN 的利润率只有 38.2%，属于“要靠投入和打法才能跑出来”的级别，不是低成本轻松切入型。
New products success rate.
What is the ratio of profitable products
Profitable (Unidentifiable released date)Profitable (Old product)Profitable (New product)Profitable (New product on old listing)New products but non profitableProfitable new products divide by brands
What is the ratio of different brands owning all profitable new products
feangliNonprofitable new products divide by brands
What is the ratio of different brands owning all nonprofitable new products
feangli#Success Rate by Entry Time
Listing结论很明确：这个市场不值得进入，属于高风险、偏早期但竞争已经开始向价格战走的类型。 现有样本里只有 2 个新品牌产品：1 个赚钱、1 个不赚钱，表面看成功率 50%，但样本太小，不能当作可复制机会；更关键的是，已出现需要投入 15,865.68 美元 才能跑起来的成功案例，而失败款又只来自同一品牌，说明这不是“很多小品牌都能轻松做成”的市场。
证据上，真正能拿来做判断的只有 feangli 这一组：B0GVST1FR1 作为新品牌新上架产品，月销 200、月营收 10,626 美元、利润率 38.2%，看起来很强，但它的早期投入高达 15,865.68 美元，其中广告就占 3,568.19 美元，这说明成功不是低成本自然出单，而是需要明显预算支撑。反过来看，同品牌的 B0GHRFLDTQ 直接落到非盈利，说明新品牌在这类商品上并不稳定，靠单款爆成的概率低。
对大品牌：可以做，但不是好市场。 这类市场当前只看到极少数新品牌结果，无法证明有足够广阔空间；如果你是大品牌，至少要按 1.6 万美元以上/单 的启动强度去准备，还要接受后续品牌、内容和推广成本，且并不保证回报。对小商家：不建议进。 目前没有看到“<300 评价、靠真实产品力稳定成功”的样本，反而是一个新品牌在高投入下才做出结果，另一款又失败，说明小商家要想进去，很容易被预算和投放门槛卡死；如果后续更多新品牌涌入并维持这种低样本高投入模式，这个品类会更像投入型竞争，而不是适合小店的机会。
How many products released each year
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
How many products released each month
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
#Net Profit Margins by Entry Time
Different profit ratios of products released in year
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2022 0 0 0 0 0 0 0 0 2023 0 0 0 0 0 0 0 0 2024 0 0 0 0 0 0 0 0 2025 0 0 0 0 0 0 0 0 2026 0 0 0 0 0 1 0 1 ≥ 10% Profitable< 10% UnprofitableUnidentifiableDifferent profit ratios of products released in month
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2025/7 0 0 0 0 0 0 0 0 2025/8 0 0 0 0 0 0 0 0 2025/9 0 0 0 0 0 0 0 0 2025/10 0 0 0 0 0 0 0 0 2025/11 0 0 0 0 0 0 0 0 2025/12 0 0 0 0 0 0 0 0 2026/1 0 0 0 0 0 0 0 1 2026/2 0 0 0 0 0 0 0 0 2026/3 0 0 0 0 0 0 0 0 2026/4 0 0 0 0 0 0 0 0 2026/5 0 0 0 0 0 1 0 0 2026/6 0 0 0 0 0 0 0 0 ≥ 10% Profitable< 10% UnprofitableUnidentifiable#Case Study
Success Casesfeangli Red Light Therapy Knee Massager for Knee Pain Relief, FSA&HSA
This listing is deemed profitablePrice (USD)$53.13Released TypeNew Release (2026-05-30)Brand is a new entry in this marketSize and Weight21.3 x 18.0 x 7.8 cm, 499.00gProfitable Factors
Based on old ASINDistinct functions and featuresDesign & Appearance
膝部包裹式红光理疗护具，带显示屏与发光点阵外观，和普通热敷护膝相比辨识度更高Key Buying Motive
三波长红光+近红外+5档振动+定时自动关机，功能组合更丰富Target Customers
针对膝盖疼痛、僵硬、关节不适人群，尤其适合需要居家可穿戴理疗的人群Early Investment
Investment
Monthly Revenue (Recent) (USD)$10,626.00200 sold in the past 30 days · as of 2026年7月Net Profit Margin
Sea Freight36.67% / 38.22%Peak / Non PeakRail Freight- / -Peak / Non PeakAir Freight32.09% / 33.64%Peak / Non PeakSales & BSR Performance